Selected research
Market Structure
Global Health and Medical Microalgae Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Health and Medical Microalgae market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Health and Medical Microalgae is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Health and Medical Microalgae is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Health and Medical Microalgae is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Health and Medical Microalgae is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Health and Medical Microalgae include DIC Corporation, Koninkliijke DSM NV, Roquette Frères, Sun chlorella, Cellana LLC, Fuji Chemical Industries Co., Ltd., Yunnan Green-A-Bio-engineering Co Ltd, Cyanotech Corporation and BASF SE, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Health and Medical Microalgae market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Health and Medical Microalgae and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Health and Medical Microalgae sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Health and Medical Microalgae market size, projected growth trends, production technologies, key applications, and end-use industries.
Health and Medical Microalgae Segment by Company
DIC Corporation
Koninkliijke DSM NV
Roquette Frères
Sun chlorella
Cellana LLC
Fuji Chemical Industries Co., Ltd.
Yunnan Green-A-Bio-engineering Co Ltd
Cyanotech Corporation
BASF SE
Parry Nutraceuticals
Beijing Gingko Group
Health and Medical Microalgae Segment by Type
Spirulina
Chlorella
Dunaliella
Aphanizomenon
Haematococcus
Crypthecodinium
Schizochytrium
Euglena
Nannochloropsis
Others
Health and Medical Microalgae Segment by Application
Nutraceuticals and Dietary Supplements
Pharmaceuticals
Health and Medical Microalgae Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Health and Medical Microalgae market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Health and Medical Microalgae and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Health and Medical Microalgae.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Health and Medical Microalgae market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Health and Medical Microalgae manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Health and Medical Microalgae in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Health and Medical Microalgae in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Spirulina
- Chlorella
- Dunaliella
- Aphanizomenon
- Haematococcus
- Crypthecodinium
- Schizochytrium
- Euglena
- Nannochloropsis
- Others
Applications
- Nutraceuticals and Dietary Supplements
- Pharmaceuticals
Companies covered
- DIC Corporation
- Koninkliijke DSM NV
- Roquette Frères
- Sun chlorella
- Cellana LLC
- Fuji Chemical Industries Co., Ltd.
- Yunnan Green-A-Bio-engineering Co Ltd
- Cyanotech Corporation
- BASF SE
- Parry Nutraceuticals
- Beijing Gingko Group
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Health and Medical Microalgae Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Health and Medical Microalgae Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Health and Medical Microalgae Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Health and Medical Microalgae Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Health and Medical Microalgae Market Dynamics
- 2.1 Health and Medical Microalgae Industry Trends
- 2.2 Health and Medical Microalgae Industry Drivers
- 2.3 Health and Medical Microalgae Industry Opportunities and Challenges
- 2.4 Health and Medical Microalgae Industry Restraints
3 Health and Medical Microalgae Market by Manufacturers
- 3.1 Global Health and Medical Microalgae Revenue by Manufacturers (2021-2026)
- 3.2 Global Health and Medical Microalgae Sales by Manufacturers (2021-2026)
- 3.3 Global Health and Medical Microalgae Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Health and Medical Microalgae Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Health and Medical Microalgae Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Health and Medical Microalgae Manufacturers, Product Type & Application
- 3.7 Global Health and Medical Microalgae Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Health and Medical Microalgae Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Health and Medical Microalgae Players Market Share by Revenue in 2025
- 3.8.3 2025 Health and Medical Microalgae Tier 1, Tier 2, and Tier 3
4 Health and Medical Microalgae Market by Type
- 4.1 Health and Medical Microalgae Type Introduction
- 4.1.1 Spirulina
- 4.1.2 Chlorella
- 4.1.3 Dunaliella
- 4.1.4 Aphanizomenon
- 4.1.5 Haematococcus
- 4.1.6 Crypthecodinium
- 4.1.7 Schizochytrium
- 4.1.8 Euglena
- 4.1.9 Nannochloropsis
- 4.1.10 Others
- 4.2 Global Health and Medical Microalgae Sales by Type
- 4.2.1 Global Health and Medical Microalgae Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Health and Medical Microalgae Sales by Type (2021-2032)
- 4.2.3 Global Health and Medical Microalgae Sales Market Share by Type (2021-2032)
- 4.3 Global Health and Medical Microalgae Revenue by Type
- 4.3.1 Global Health and Medical Microalgae Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Health and Medical Microalgae Revenue by Type (2021-2032)
- 4.3.3 Global Health and Medical Microalgae Revenue Market Share by Type (2021-2032)
5 Health and Medical Microalgae Market by Application
- 5.1 Health and Medical Microalgae Application Introduction
- 5.1.1 Nutraceuticals and Dietary Supplements
- 5.1.2 Pharmaceuticals
- 5.2 Global Health and Medical Microalgae Sales by Application
- 5.2.1 Global Health and Medical Microalgae Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Health and Medical Microalgae Sales by Application (2021-2032)
- 5.2.3 Global Health and Medical Microalgae Sales Market Share by Application (2021-2032)
- 5.3 Global Health and Medical Microalgae Revenue by Application
- 5.3.1 Global Health and Medical Microalgae Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Health and Medical Microalgae Revenue by Application (2021-2032)
- 5.3.3 Global Health and Medical Microalgae Revenue Market Share by Application (2021-2032)
6 Global Health and Medical Microalgae Sales by Region
- 6.1 Global Health and Medical Microalgae Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Health and Medical Microalgae Sales by Region (2021-2032)
- 6.2.1 Global Health and Medical Microalgae Sales by Region (2021-2026)
- 6.2.2 Global Health and Medical Microalgae Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Health and Medical Microalgae Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Health and Medical Microalgae Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Health and Medical Microalgae Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Health and Medical Microalgae Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Health and Medical Microalgae Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Health and Medical Microalgae Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Health and Medical Microalgae Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Health and Medical Microalgae Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Health and Medical Microalgae Revenue by Region
- 7.1 Global Health and Medical Microalgae Revenue by Region
- 7.1.1 Global Health and Medical Microalgae Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Health and Medical Microalgae Revenue by Region (2021-2026)
- 7.1.3 Global Health and Medical Microalgae Revenue by Region (2027-2032)
- 7.1.4 Global Health and Medical Microalgae Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Health and Medical Microalgae Revenue (2021-2032)
- 7.2.2 North America Health and Medical Microalgae Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Health and Medical Microalgae Revenue (2021-2032)
- 7.3.2 Europe Health and Medical Microalgae Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Health and Medical Microalgae Revenue (2021-2032)
- 7.4.2 Asia-Pacific Health and Medical Microalgae Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Health and Medical Microalgae Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Health and Medical Microalgae Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 DIC Corporation
- 8.1.1 DIC Corporation Company Information
- 8.1.2 DIC Corporation Business Overview
- 8.1.3 DIC Corporation Health and Medical Microalgae Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 DIC Corporation Health and Medical Microalgae Product Portfolio
- 8.1.5 DIC Corporation Recent Developments
- 8.2 Koninkliijke DSM NV
- 8.2.1 Koninkliijke DSM NV Company Information
- 8.2.2 Koninkliijke DSM NV Business Overview
- 8.2.3 Koninkliijke DSM NV Health and Medical Microalgae Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Koninkliijke DSM NV Health and Medical Microalgae Product Portfolio
- 8.2.5 Koninkliijke DSM NV Recent Developments
- 8.3 Roquette Frères
- 8.3.1 Roquette Frères Company Information
- 8.3.2 Roquette Frères Business Overview
- 8.3.3 Roquette Frères Health and Medical Microalgae Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Roquette Frères Health and Medical Microalgae Product Portfolio
- 8.3.5 Roquette Frères Recent Developments
- 8.4 Sun chlorella
- 8.4.1 Sun chlorella Company Information
- 8.4.2 Sun chlorella Business Overview
- 8.4.3 Sun chlorella Health and Medical Microalgae Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Sun chlorella Health and Medical Microalgae Product Portfolio
- 8.4.5 Sun chlorella Recent Developments
- 8.5 Cellana LLC
- 8.5.1 Cellana LLC Company Information
- 8.5.2 Cellana LLC Business Overview
- 8.5.3 Cellana LLC Health and Medical Microalgae Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Cellana LLC Health and Medical Microalgae Product Portfolio
- 8.5.5 Cellana LLC Recent Developments
- 8.6 Fuji Chemical Industries Co., Ltd.
- 8.6.1 Fuji Chemical Industries Co., Ltd. Company Information
- 8.6.2 Fuji Chemical Industries Co., Ltd. Business Overview
- 8.6.3 Fuji Chemical Industries Co., Ltd. Health and Medical Microalgae Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Fuji Chemical Industries Co., Ltd. Health and Medical Microalgae Product Portfolio
- 8.6.5 Fuji Chemical Industries Co., Ltd. Recent Developments
- 8.7 Yunnan Green-A-Bio-engineering Co Ltd
- 8.7.1 Yunnan Green-A-Bio-engineering Co Ltd Company Information
- 8.7.2 Yunnan Green-A-Bio-engineering Co Ltd Business Overview
- 8.7.3 Yunnan Green-A-Bio-engineering Co Ltd Health and Medical Microalgae Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Yunnan Green-A-Bio-engineering Co Ltd Health and Medical Microalgae Product Portfolio
- 8.7.5 Yunnan Green-A-Bio-engineering Co Ltd Recent Developments
- 8.8 Cyanotech Corporation
- 8.8.1 Cyanotech Corporation Company Information
- 8.8.2 Cyanotech Corporation Business Overview
- 8.8.3 Cyanotech Corporation Health and Medical Microalgae Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Cyanotech Corporation Health and Medical Microalgae Product Portfolio
- 8.8.5 Cyanotech Corporation Recent Developments
- 8.9 BASF SE
- 8.9.1 BASF SE Company Information
- 8.9.2 BASF SE Business Overview
- 8.9.3 BASF SE Health and Medical Microalgae Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 BASF SE Health and Medical Microalgae Product Portfolio
- 8.9.5 BASF SE Recent Developments
- 8.10 Parry Nutraceuticals
- 8.10.1 Parry Nutraceuticals Company Information
- 8.10.2 Parry Nutraceuticals Business Overview
- 8.10.3 Parry Nutraceuticals Health and Medical Microalgae Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Parry Nutraceuticals Health and Medical Microalgae Product Portfolio
- 8.10.5 Parry Nutraceuticals Recent Developments
- 8.11 Beijing Gingko Group
- 8.11.1 Beijing Gingko Group Company Information
- 8.11.2 Beijing Gingko Group Business Overview
- 8.11.3 Beijing Gingko Group Health and Medical Microalgae Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Beijing Gingko Group Health and Medical Microalgae Product Portfolio
- 8.11.5 Beijing Gingko Group Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Health and Medical Microalgae Value Chain Analysis
- 9.1.1 Health and Medical Microalgae Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Health and Medical Microalgae Production Mode & Process
- 9.2 Health and Medical Microalgae Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Health and Medical Microalgae Distributors
- 9.2.3 Health and Medical Microalgae Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst